Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oestrogen Supplementation, Mainly Diethylstilbestrol, for Preventing Miscarriages and Other Adverse Pregnancy Outcomes." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438486/2/Palliative_drug_treatments_for_breathlessness_in_cystic_fibrosis:_Cochrane_systematic_review. Accessed 20 April 2024.
Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438486/2/Palliative_drug_treatments_for_breathlessness_in_cystic_fibrosis:_Cochrane_systematic_review. Accessed April 20, 2024.
Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438486/2/Palliative_drug_treatments_for_breathlessness_in_cystic_fibrosis:_Cochrane_systematic_review
Oestrogen Supplementation, Mainly Diethylstilbestrol, for Preventing Miscarriages and Other Adverse Pregnancy Outcomes [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438486/2/Palliative_drug_treatments_for_breathlessness_in_cystic_fibrosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes
ID - 438486
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438486/2/Palliative_drug_treatments_for_breathlessness_in_cystic_fibrosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -